Access cutting-edge respiratory virus infection treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.
Access respiratory virus infection specialists in Detroit at no cost
This study follows strict safety protocols and ethical guidelines
All study-related respiratory virus infection treatment provided free
The purpose of this research study is to try to see whether an experimental drug, PUL 042 Inhalation Solution (PUL 042), is effective in reducing the severity of lung infections in patients with hematologic malignancies and recipients of hematopoietic stem cell transplantation with documented viral infections due to PIV, hMPV, or RSV. PUL-042 or a placebo will be administered 3 times over a 6-day period. The total duration of the study will be approximately 30 days.
Sponsor: Pulmotect, Inc.
Check if you qualify for this respiratory virus infection clinical trial in Detroit, MI
If you're searching for respiratory virus infection treatment options in Detroit, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced respiratory virus infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.